GH Research (GHRS) Capital Expenditures (2021 - 2026)
GH Research's Capital Expenditures came in at $143,000 for Q2 2026, up 142.4% from $59,000 a year earlier.
Powered by 
Analysis
GH Research (GHRS) Capital Expenditures (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, GH Research reported Capital Expenditures of $138,000, up 50.0% year-over-year; for FY2025, it was $121,000, up 146.9% from FY2024.
- Capital Expenditures carries a four-year compound annual growth rate of 3.9% (FY2021 to FY2025).
- Going back by year, Capital Expenditures was $49,000 in FY2024 (-51.0%), $100,000 in FY2023 (+49.3%), $67,000 in FY2022 (-35.6%) and $104,000 in FY2021.
- The Q2 2026 figure represents the highest quarterly Capital Expenditures since Q4 2021.
- Year-over-year, Capital Expenditures increased in four of the last seven quarters, with growth averaging 216.9%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q3 2025 (growth of 875.0%), and the weakest in Q4 2022 (a decline of 90.5%).
- Business Quant data shows GHRS's Capital Expenditures at -$63,000 (Q1 2026), $19,000 (Q4 2025) and $39,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 573.00 Mn |
| 10 | GH Research | 1.18 Bn | 99.82 Mn | - | 17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 143,000.00 |
| Mar 31, 2026 | -63,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 18,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Dec 31, 2021 | 189,000.00 |
| Sep 30, 2021 | -50,000.00 |
API Access
GH Research Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "GHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();